Bacil Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BSE:524516 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
21 Mar 25	Sell₹7,901,368	Prakash Shah	Individual	207,931	₹38.00
10 Mar 25	Sell₹4,126,487	Prakash Shah	Individual	114,976	₹35.89
20 Sep 24	Sell₹4,011,090	Prakash Shah	Individual	156,500	₹25.63

Insider Trading Volume

Insider Buying: 524516 insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 524516?
Owner Type	Number of Shares	Ownership Percentage
Institutions	0	0%
Private Companies	72,055	0.502%
Public Companies	887,300	6.18%
Individual Insiders	911,210	6.35%
General Public	12,482,435	87%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 143.7%.

Top Shareholders

Top 14 shareholders own 13.03% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.18%	GB Logistics Commerce Limited	887,300	₹38.8m	-3.27%	no data
1.16%	Parikshit Notaria	165,861	₹7.2m	0%	no data
1.16%	Saroj Mehta	165,861	₹7.2m	0%	no data
0.84%	Randeep Singh	120,089	₹5.2m	-28.3%	no data
0.72%	Manubhai Shah	103,000	₹4.5m	0%	no data
0.66%	Gaurang Shah	94,900	₹4.1m	0%	no data
0.54%	Jayesh Patel	77,419	₹3.4m	3.54%	no data
0.43%	Navin Mehta	61,801	₹2.7m	0%	no data
0.43%	Purushottam Bohra	61,779	₹2.7m	0%	no data
0.43%	Yellowstone Ventures Llp	61,055	₹2.7m	0%	no data
0.42%	Aditya Patel	60,000	₹2.6m	0%	no data
0.075%	Gulecha Investment & Trading Company Pvt Ltd	10,800	₹472.0k	-92.9%	no data
0.0035%	Prakash Shah	500	₹21.8k	-99.8%	no data
0.0014%	Khem-Sum Apparels Overseas Ltd	200	₹8.7k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 12:05
End of Day Share Price	2025/05/14 00:00
Earnings	2024/12/31
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bacil Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.